| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 商砼(元) | 406,512,165.76 | 163,725,297.78 | 442,621,874.78 | 189,161,550.09 |
| 生物医药(元) | 1,881,828,940.28 | 992,936,139.87 | 1,898,005,471.22 | 981,727,231.03 |
| 养老健康(元) | 90,993,494.34 | 51,053,695.45 | 125,049,020.21 | 69,021,036.29 |
| 其他(元) | 63,670,613.48 | 31,099,875.15 | 66,465,831.54 | 33,434,677.96 |
| 营业成本(元) | ||||
| 商砼(元) | 311,609,162.16 | 137,101,495.31 | 331,015,503.15 | 149,114,805.44 |
| 生物医药(元) | 524,458,824.68 | 274,379,338.38 | 542,298,350.19 | 272,075,325.07 |
| 养老健康(元) | 116,063,620.17 | 55,883,500.36 | 137,058,982.01 | 75,527,674.57 |
| 其他(元) | 43,208,714.91 | 18,268,685.21 | 40,275,583.25 | 16,558,963.06 |
| 毛利(元) | ||||
| 商砼(元) | 94,903,003.60 | 26,623,802.47 | 111,606,371.63 | 40,046,744.65 |
| 生物医药(元) | 1,357,370,115.60 | 718,556,801.49 | 1,355,707,121.03 | 709,651,905.96 |
| 养老健康(元) | -25,070,125.83 | -4,829,804.91 | -12,009,961.80 | -6,506,638.28 |
| 其他(元) | 20,461,898.57 | 12,831,189.94 | 26,190,248.29 | 16,875,714.90 |
| 毛利率(%) | ||||
| 商砼(%) | 23.35 | 16.26 | 25.21 | 21.17 |
| 生物医药(%) | 72.13 | 72.37 | 71.43 | 72.29 |
| 养老健康(%) | -27.55 | -9.46 | -9.60 | -9.43 |
| 其他(%) | 32.14 | 41.26 | 39.40 | 50.47 |
| 收入构成(%) | ||||
| 商砼(%) | 16.64 | 13.22 | 17.48 | 14.86 |
| 生物医药(%) | 77.03 | 80.15 | 74.96 | 77.10 |
| 养老健康(%) | 3.72 | 4.12 | 4.94 | 5.42 |
| 其他(%) | 2.61 | 2.51 | 2.62 | 2.63 |
| 毛利构成(%) | ||||
| 商砼(%) | 6.56 | 3.53 | 7.53 | 5.27 |
| 生物医药(%) | 93.76 | 95.40 | 91.51 | 93.37 |
| 养老健康(%) | -1.73 | -0.64 | -0.81 | -0.86 |
| 其他(%) | 1.41 | 1.70 | 1.77 | 2.22 |